A novel 2'-(N-methylpyridinium acetate) prodrug of paclitaxel induces superior antitumor responses in preclinical cancer models.

PubWeight™: 1.19‹?› | Rank: Top 10%

🔗 View Article (PMID 12236791)

Published in Bioconjug Chem on September 18, 2002

Authors

Wolfgang Wrasidlo1, Gerhard Gaedicke, Rodney Kiplin Guy, Johanne Renaud, Emmanuel Pitsinos, Kyriaco C Nicolaou, Ralph A Reisfeld, Holger N Lode

Author Affiliations

1: Charité Children's Hospital, Humboldt University, Berlin, Germany.

Articles by these authors

Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma. N Engl J Med (2010) 6.34

Tumor regression by targeted gene delivery to the neovasculature. Science (2002) 4.78

Targeting tumor-associated macrophages as a novel strategy against breast cancer. J Clin Invest (2006) 3.77

T cell homeostatic proliferation elicits effective antitumor autoimmunity. J Clin Invest (2002) 3.41

Antibody targeted drugs as cancer therapeutics. Nat Rev Drug Discov (2006) 3.08

Targeting tumor-associated fibroblasts improves cancer chemotherapy by increasing intratumoral drug uptake. J Clin Invest (2006) 2.64

Viral agents of acute gastroenteritis in German children: prevalence and molecular diversity. J Med Virol (2003) 2.56

A DNA vaccine against VEGF receptor 2 prevents effective angiogenesis and inhibits tumor growth. Nat Med (2002) 2.55

Cancer associated fibroblasts promote tumor growth and metastasis by modulating the tumor immune microenvironment in a 4T1 murine breast cancer model. PLoS One (2009) 2.47

Primary ciliary dyskinesia associated with normal axoneme ultrastructure is caused by DNAH11 mutations. Hum Mutat (2008) 2.03

A phase I clinical trial of the hu14.18-IL2 (EMD 273063) as a treatment for children with refractory or recurrent neuroblastoma and melanoma: a study of the Children's Oncology Group. Clin Cancer Res (2006) 1.91

Intralesional targeted alpha therapy for metastatic melanoma. Cancer Biol Ther (2005) 1.71

Inhibition of alpha(v)beta3 integrin survival signaling enhances antiangiogenic and antitumor effects of radiotherapy. Clin Cancer Res (2005) 1.64

Risk factors for suicide completion in borderline personality disorder: a case-control study of cluster B comorbidity and impulsive aggression. J Clin Psychiatry (2007) 1.58

Antitumor activity of hu14.18-IL2 in patients with relapsed/refractory neuroblastoma: a Children's Oncology Group (COG) phase II study. J Clin Oncol (2010) 1.57

SOX2 gene regulates the transcriptional network of oncogenes and affects tumorigenesis of human lung cancer cells. PLoS One (2012) 1.55

DNA vaccination against VEGF receptor 2 reduces atherosclerosis in LDL receptor-deficient mice. Arterioscler Thromb Vasc Biol (2007) 1.54

Genotypes of NK cell KIR receptors, their ligands, and Fcγ receptors in the response of neuroblastoma patients to Hu14.18-IL2 immunotherapy. Cancer Res (2010) 1.51

Enhanced activity of hu14.18-IL2 immunocytokine against murine NXS2 neuroblastoma when combined with interleukin 2 therapy. Clin Cancer Res (2004) 1.46

An examination of DSM-IV depressive symptoms and risk for suicide completion in major depressive disorder: a psychological autopsy study. J Affect Disord (2006) 1.44

Nutrient mixture including vitamin C, L-lysine, L-proline, and epigallocatechin is ineffective against tumor growth and metastasis in a syngeneic neuroblastoma model. Pediatr Blood Cancer (2008) 1.43

Continuous veno-venous single-pass albumin hemodiafiltration in children with acute liver failure. Pediatr Crit Care Med (2011) 1.43

Tumor-associated macrophages regulate murine breast cancer stem cells through a novel paracrine EGFR/Stat3/Sox-2 signaling pathway. Stem Cells (2013) 1.33

Bioactivation of self-immolative dendritic prodrugs by catalytic antibody 38C2. J Am Chem Soc (2004) 1.20

Characterization of stem cell-like cancer cells in immune-competent mice. Blood (2006) 1.19

NXS2 murine neuroblastomas express increased levels of MHC class I antigens upon recurrence following NK-dependent immunotherapy. Cancer Immunol Immunother (2003) 1.16

NK cells engineered to express a GD2 -specific antigen receptor display built-in ADCC-like activity against tumour cells of neuroectodermal origin. J Cell Mol Med (2012) 1.16

Intratumoral immunocytokine treatment results in enhanced antitumor effects. Cancer Immunol Immunother (2008) 1.13

A DNA vaccine targeting survivin combines apoptosis with suppression of angiogenesis in lung tumor eradication. Cancer Res (2005) 1.12

A Legumain-based minigene vaccine targets the tumor stroma and suppresses breast cancer growth and angiogenesis. Cancer Immunol Immunother (2007) 1.08

Synthesis, hydrolytic activation and cytotoxicity of etoposide prodrugs. Bioorg Med Chem Lett (2002) 1.08

Anti-neuroblastoma effect of ch14.18 antibody produced in CHO cells is mediated by NK-cells in mice. Mol Immunol (2005) 1.08

Transcription factor Fos-related antigen 1 is an effective target for a breast cancer vaccine. Proc Natl Acad Sci U S A (2003) 1.06

Inhibition of neuroblastoma tumor growth by targeted delivery of microRNA-34a using anti-disialoganglioside GD2 coated nanoparticles. PLoS One (2012) 1.06

SOX2 regulates apoptosis through MAP4K4-survivin signaling pathway in human lung cancer cells. Carcinogenesis (2013) 1.05

Immunostimulatory effects of low-dose cyclophosphamide are controlled by inducible nitric oxide synthase. Cancer Res (2005) 1.04

Neuroblastoma triggers an immunoevasive program involving galectin-1-dependent modulation of T cell and dendritic cell compartments. Int J Cancer (2011) 1.03

Molecular mechanisms of mistletoe plant extract-induced apoptosis in acute lymphoblastic leukemia in vivo and in vitro. Cancer Lett (2008) 0.99

T cell-mediated suppression of angiogenesis results in tumor protective immunity. Blood (2005) 0.99

Ch14.18 antibody produced in CHO cells in relapsed or refractory Stage 4 neuroblastoma patients: a SIOPEN Phase 1 study. MAbs (2013) 0.97

Immature platelet count: a simple parameter for distinguishing thrombocytopenia in pediatric acute lymphocytic leukemia from immune thrombocytopenia. Pediatr Blood Cancer (2010) 0.96

Reducing the peptidyl features of caspase-3 inhibitors: a structural analysis. J Med Chem (2004) 0.96

A design thinking approach to effective vaccine safety communication. Curr Drug Saf (2015) 0.96

Yes-associated protein (YAP) increases chemosensitivity of hepatocellular carcinoma cells by modulation of p53. Cancer Biol Ther (2013) 0.95

Mouse models for melanoma: a personal perspective. Exp Dermatol (2009) 0.95

IMD-0354 targets breast cancer stem cells: a novel approach for an adjuvant to chemotherapy to prevent multidrug resistance in a murine model. PLoS One (2013) 0.95

Oral DNA vaccines target the tumor vasculature and microenvironment and suppress tumor growth and metastasis. Immunol Rev (2008) 0.95

Differential internalization of hu14.18-IL2 immunocytokine by NK and tumor cell: impact on conjugation, cytotoxicity, and targeting. J Leukoc Biol (2011) 0.95

Control-group study of an intervention training program for youth suicide prevention. Suicide Life Threat Behav (2007) 0.94

Synthetic enzyme inhibitor: a novel targeting ligand for nanotherapeutic drug delivery inhibiting tumor growth without systemic toxicity. Nanomedicine (2011) 0.94

A DNA vaccine targeting Fos-related antigen 1 enhanced by IL-18 induces long-lived T-cell memory against tumor recurrence. Cancer Res (2005) 0.93

Comparison of immunogenicity and tolerability of a virosome-adjuvanted and a split influenza vaccine in children. Pediatr Infect Dis J (2004) 0.93

Fra-1 promotes breast cancer chemosensitivity by driving cancer stem cells from dormancy. Cancer Res (2012) 0.93

A novel DNA vaccine encoding PDGFRbeta suppresses growth and dissemination of murine colon, lung and breast carcinoma. Vaccine (2006) 0.92

Is the goal of mastication reached in young dentates, aged dentates and aged denture wearers? Br J Nutr (2007) 0.92

Intratumoral hu14.18-IL-2 (IC) induces local and systemic antitumor effects that involve both activated T and NK cells as well as enhanced IC retention. J Immunol (2012) 0.91

Characterization of GD2 peptide mimotope DNA vaccines effective against spontaneous neuroblastoma metastases. Cancer Res (2006) 0.91

Targeted therapeutic remodeling of the tumor microenvironment improves an HER-2 DNA vaccine and prevents recurrence in a murine breast cancer model. Cancer Res (2011) 0.91

Smac mimetic LBW242 sensitizes XIAP-overexpressing neuroblastoma cells for TNF-α-independent apoptosis. Cancer Res (2012) 0.90

DNA-based vaccines activate innate and adaptive antitumor immunity by engaging the NKG2D receptor. Proc Natl Acad Sci U S A (2005) 0.89

The anti-tumor effect of resveratrol alone or in combination with immunotherapy in a neuroblastoma model. Cancer Immunol Immunother (2011) 0.87

Induction of IgG antibodies against the GD2 carbohydrate tumor antigen by vaccination with peptide mimotopes. Eur J Immunol (2006) 0.87

Quality of life in childhood immune thrombocytopenia: international validation of the kids' ITP tools. Pediatr Blood Cancer (2012) 0.87

Adolescent suicide in Quebec and prior utilization of medical services. Can J Public Health (2004) 0.86

A DNA-based cancer vaccine enhances lymphocyte cross talk by engaging the NKG2D receptor. Blood (2005) 0.86

Vascular endothelial growth factor receptor 2-based DNA immunization delays development of herpetic stromal keratitis by antiangiogenic effects. J Immunol (2006) 0.86

Vaccination against VEGFR2 attenuates initiation and progression of atherosclerosis. Arterioscler Thromb Vasc Biol (2007) 0.86

Endoglin (CD105) is a target for an oral DNA vaccine against breast cancer. Cancer Immunol Immunother (2006) 0.86

Cardiac rescue with enoximone in volume and catecholamine refractory septic shock. Pediatr Crit Care Med (2003) 0.85

Fractalkine (CX3CL1)- and interleukin-2-enriched neuroblastoma microenvironment induces eradication of metastases mediated by T cells and natural killer cells. Cancer Res (2007) 0.85

Survivin minigene DNA vaccination is effective against neuroblastoma. Int J Cancer (2009) 0.84

Supporting the hypothesis of pregnancy as a tumor: survivin is upregulated in normal pregnant mice and participates in human trophoblast proliferation. Am J Reprod Immunol (2008) 0.84

FLK-1-based minigene vaccines induce T cell-mediated suppression of angiogenesis and tumor protective immunity in syngeneic BALB/c mice. Vaccine (2006) 0.84

Disialoganglioside-specific human natural killer cells are effective against drug-resistant neuroblastoma. Cancer Immunol Immunother (2015) 0.83

A novel transgenic mouse model for immunological evaluation of carcinoembryonic antigen-based DNA minigene vaccines. J Clin Invest (2004) 0.83

Immunotherapy with a posttranscriptionally modified DNA vaccine induces complete protection against metastatic neuroblastoma. Blood (2002) 0.83

Pulmonary symptoms in Kawasaki disease. Pediatr Infect Dis J (2004) 0.83

Salmonella SL7207 application is the most effective DNA vaccine delivery method for successful tumor eradication in a murine model for neuroblastoma. Cancer Lett (2013) 0.83

Outcomes in women diagnosed with borderline personality disorder in adolescence. J Can Acad Child Adolesc Psychiatry (2011) 0.83

Youth and young adult suicide: a study of life trajectory. J Psychiatr Res (2011) 0.83

Vaccination against TIE2 reduces atherosclerosis. Atherosclerosis (2008) 0.83

Adenovirus fiber shaft contains a trimerization element that supports peptide fusion for targeted gene delivery. J Virol (2006) 0.83

Immunological tumor destruction in a murine melanoma model by targeted LTalpha independent of secondary lymphoid tissue. Cancer Immunol Immunother (2007) 0.83

Plasmid DNA encoding human carcinoembryonic antigen (CEA) adsorbed onto cationic microparticles induces protective immunity against colon cancer in CEA-transgenic mice. Vaccine (2003) 0.82

Completed suicides among Quebec adolescents involved with juvenile justice and child welfare services. Suicide Life Threat Behav (2004) 0.82

Multidrug resistance-1 (MDR-1): a new target for T cell-based immunotherapy. FASEB J (2004) 0.82

Validated detection of anti-GD2 antibody ch14.18/CHO in serum of neuroblastoma patients using anti-idiotype antibody ganglidiomab. J Immunol Methods (2013) 0.82

Arylaminoethyl amides as novel non-covalent cathepsin K inhibitors. J Med Chem (2002) 0.81

Synthesis and characterization of a catalytic antibody-HPMA copolymer-Conjugate as a tool for tumor selective prodrug activation. Bioorg Med Chem (2002) 0.81

Pulmonary hypertension in a case of Hb-Mainz hemolytic anemia. J Pediatr Hematol Oncol (2007) 0.80

Solid phase synthesis of selective caspase-3 peptide inhibitors. Bioorg Med Chem (2004) 0.80

An examination of DSM-IV borderline personality disorder symptoms and risk for death by suicide: a psychological autopsy study. Can J Psychiatry (2009) 0.80